Nicolas Dreyfus

Statistics

Publications

Citations

156

H-Index

Active since

2012

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (United Kingdom)

Invicro (United States)

University of East Anglia

Eli Lilly (Singapore)

Nicolas Dreyfus is an author at Eli Lilly (United States) specializing in enzyme inhibition, tau post-translational modifications, and neuropharmacology.

Publications per year

2012–2025

Publications

PET ligands [ 18 F]LSN3316612 and [ 11 C]LSN3316612 quantify O -linked-β- N -acetyl-glucosamine hydrolase in the brain

Shuiyu Lu, Mohammad B. Haskali, Kevin M. Ruley et al. · Science Translational Medicine · 2020 · 32 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Harnessing applied potential to oxidation in water

Benjamin R. Buckley, Yohan Chan, Nicolas Dreyfus et al. · Green Chemistry · 2012 · 25 citations · Full text

Engineering, Chemical Engineering, Chemistry +17

Chemoselective Oxidation of Sulfides to Sulfoxides with Urea–Hydrogen Peroxide Complex Catalysed by Diselenide

Philip C. Bulman Page, Benjamin R. Buckley, Claire Elliott et al. · Synlett · 2015 · 21 citations · Full text

Natural Sciences, Chemical Engineering, Chemistry +9

Brain target occupancy of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme: Translation from rat to human

Sergey Shcherbinin, William Kielbasa, Susan L. DuBois et al. · Alzheimer s & Dementia · 2020 · 21 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Discovery and clinical translation of ceperognastat, an O‐GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease

William Kielbasa, Paul Goldsmith, Kevin B. Donnelly et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2024 · 21 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

1–5 of 8